BBOT
BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT)
$95
About BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT)
Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.
Details
Daily high
$9.12
Daily low
$8.82
Price at open
$9.02
52 Week High
$14.87
52 Week Low
$7.00
Market cap
724.8M
Dividend yield
-
Volume
446,873
Avg. volume
260,678
P/E ratio
-.01
BridgeBio Oncology Therapeutics, Inc. - Common Stock News
Details
Daily high
$9.12
Daily low
$8.82
Price at open
$9.02
52 Week High
$14.87
52 Week Low
$7.00
Market cap
724.8M
Dividend yield
-
Volume
446,873
Avg. volume
260,678
P/E ratio
-.01